Alpha-GPC
A multicenter RCT in mild-to-moderate Alzheimer's dementia (De Jesus Moreno, 2003, n=261) found 1200mg/day improved ADAS-Cog, MMSE and global scores versus placebo at 90 and 180 days, and a 2023 meta-analysis supports benefit in cerebrovascular cognitive impairment. In healthy men, a single 315–630mg dose improved Stroop performance but not N-Back or Flanker (Kerksick 2024). Sports trials are inconsistent: a lower-body force gain after 6 days at 600mg (Bellar 2015), no strength effect at 250–500mg for 7 days, and no power-output effect after a single 630mg dose.
Evidence reviewed:
Mechanism of action
Alpha-GPC (alpha-glycerylphosphorylcholine) is the most bioavailable choline precursor. It delivers choline directly across the blood-brain barrier, where it is used to synthesise acetylcholine. It also supports cell membrane phospholipid synthesis. It is often marketed for growth hormone release, but a 2024 RCT at 630mg found no growth hormone difference versus placebo.
Clinical evidence summary
A multicenter RCT in mild-to-moderate Alzheimer's dementia (De Jesus Moreno, 2003, n=261) found 1200mg/day improved ADAS-Cog, MMSE and global scores versus placebo at 90 and 180 days, and a 2023 meta-analysis supports benefit in cerebrovascular cognitive impairment. In healthy men, a single 315–630mg dose improved Stroop performance but not N-Back or Flanker (Kerksick 2024). Sports trials are inconsistent: a lower-body force gain after 6 days at 600mg (Bellar 2015), no strength effect at 250–500mg for 7 days, and no power-output effect after a single 630mg dose.
Human effect matrix
Based on human clinical trials only. Animal and in-vitro data excluded.
| Effect | Evidence | Magnitude | Studies |
|---|---|---|---|
| Acetylcholine Synthesis | strong | Large | 2 |
| Memory & Cognition | moderate | Moderate | 2 |
| Athletic Power Output | mixed | Small | 3 |
| Neuroprotection | moderate | Moderate | 2 |
Evidence key: Strong = multiple consistent RCTs · Moderate = smaller/fewer RCTs · Preliminary = early trials or small n · Mixed = conflicting results
Documented benefits
- Cognition in Alzheimer's and cerebrovascular dementia (1200mg/day)
- Acute Stroop (executive) performance in healthy men
- Raises plasma choline
Side effects & cautions
- Well tolerated
- Headache if combined with other cholinergics
- 500mg/day significantly suppressed serum TSH (thyroid-stimulating hormone) in a 7-day trial
How to take
Stacking recommendations
Ingredients that pair well with Alpha-GPC and why.
Alpha-GPC provides immediate acetylcholine support; Lion's Mane drives long-term NGF synthesis. Neither overlaps mechanistically — a clean acute + long-term pairing.
Alpha-GPC handles acute memory encoding via acetylcholine; Bacopa handles memory consolidation and storage. Together they cover both encoding and consolidation stages of memory formation.
Huperzine A prevents acetylcholine breakdown while Alpha-GPC increases acetylcholine synthesis. Powerful combination in theory — but use with caution and low doses, as cholinergic overload (nausea, headache, muscle cramps) is a real risk. Not recommended without experience.
Frequently asked questions
Alpha-GPC vs Citicoline — which is better for focus?
Both are excellent. Alpha-GPC has a slight edge for acute cholinergic effects and is preferred for workout performance. Citicoline also provides cytidine (uridine precursor), giving it a broader neuroprotective profile. For pure focus and acetylcholine, Alpha-GPC wins slightly; for comprehensive brain health support, Citicoline is more complete. Don't stack them together — you'll get too much choline activity.
Is it safe to combine Alpha-GPC with Huperzine A?
Use caution. Both increase acetylcholine (Alpha-GPC via synthesis, Huperzine A via inhibiting breakdown). The combination is potent and can cause cholinergic overstimulation — symptoms include nausea, headache, excessive salivation, and muscle cramps. If combining, use lower doses of each (e.g. 200mg Alpha-GPC + 50mcg Huperzine A) and do not take daily.
Why does Alpha-GPC powder go sticky?
Alpha-GPC is highly hygroscopic — it absorbs water from the air quickly. This is normal and doesn't affect potency. Store in an airtight container in a cool, dry place. Capsule form avoids this problem entirely.
Is there a cardiovascular risk with Alpha-GPC?
Unresolved. The CARDIA cohort study (published 2024) linked higher plasma choline — not alpha-GPC supplements — with incident cardiovascular disease, while a meta-analysis of dietary choline intake found no association. No study has tested alpha-GPC supplementation directly for cardiovascular outcomes. If you have cardiovascular disease, discuss it with your doctor.
Top stacks containing Alpha-GPC
Alpha-GPC in Canada
Alpha-GPC (also called choline alfoscerate or L-alpha-glycerylphosphorylcholine, AGPC) has been reviewed by Health Canada's Food Directorate as a potential supplemental ingredient in foods. Health Canada's published safety assessment states "Health Canada plans to allow the use of AGPC as a supplemental ingredient in foods under certain conditions," after concluding "AGPC once ingested is converted to choline and there is no indication that AGPC represents any additional risk compared to any other sources of choline." That safety conclusion is Health Canada's published position on Alpha-GPC as a food ingredient.
Health Canada's safety conclusion
Health Canada's Food Directorate completed a dedicated safety assessment of AGPC before proposing to permit its use as a supplemental food ingredient. The assessment concludes "there is no indication that AGPC represents any additional risk compared to any other sources of choline," and separately states "there are no anticipated risks from consuming AGPC in excess of 1200 mg/day, based on studies testing lower doses." Health Canada notes it "plans to allow the use of AGPC as a supplemental ingredient in foods under certain conditions" — meaning conditions on maximum use levels and labelling still apply.
What this does not establish
This safety assessment addresses AGPC's status as a food ingredient and choline source, not a Health Canada-approved cognitive-effect claim for Alpha-GPC as a standalone natural health product. Readers should not read Health Canada's AGPC safety conclusion as an endorsement of any specific focus, memory or acetylcholine claim; a licensed Canadian product making such a claim would carry its own NPN and its own reviewed use statement.
Products in Canada
- Qualia Mind7.3/10No NPN found (checked 2026-10-07)Local price: $190/month
- Alpha Brain5.2/10No NPN found (checked 2026-10-07)Local price: $108/month
Health Canada (NPN)
Is Alpha-GPC legal to sell in Canada?
Health Canada's Food Directorate has assessed Alpha-GPC (AGPC) as a supplemental food ingredient and states it "plans to allow the use of AGPC as a supplemental ingredient in foods under certain conditions," after finding "no indication that AGPC represents any additional risk compared to any other sources of choline." This is a food-ingredient safety pathway rather than a specific cognitive-supplement claim approval.
Did Health Canada set an upper safety limit for Alpha-GPC intake?
Health Canada's safety assessment states "there are no anticipated risks from consuming AGPC in excess of 1200 mg/day, based on studies testing lower doses," as part of its choline-source safety review — not as an approved supplement dosing range for a specific cognitive claim.
Sources: Health Canada — Summary of Health Canada's safety assessment of L-alpha-glycerylphosphorylcholine for use as a supplemental ingredient · Health Canada — Summary of Health Canada's safety assessment of L-alpha-glycerylphosphorylcholine for use as a supplemental ingredient · Health Canada — Summary of Health Canada's safety assessment of L-alpha-glycerylphosphorylcholine for use as a supplemental ingredient
Regulatory note
Natural health products available in Canada are regulated by Health Canada under the Natural Health Products Regulations. Where a product holds an NPN (Natural Product Number), Health Canada says that number "assures consumers that the product has been reviewed and approved by Health Canada for safety and efficacy"; it also states, "To be licensed in Canada, natural health products must be safe, effective, of high quality" (canada.ca, checked 2026-10-08). Cross-border imports without an NPN are not Health Canada licensed. This page is for educational purposes only and is not medical advice. Consult a qualified healthcare professional before starting any supplement.
Sources (7)expand
- PMID 36683513Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis (2023)
- PMID 12637119Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate (De Jesus Moreno, 2003) (2003)
- PMID 39683633Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men (2024)
- PMID 26582972The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength (Bellar et al., 2015) (2015)
- PMID 29042830Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance (2017)
- PMID 1428296A comparative study of free plasma choline levels following intramuscular administration of L-alpha-glycerylphosphorylcholine and citicoline in normal volunteers (1992)
- PMID 37865185Choline metabolites and incident cardiovascular disease in a prospective cohort of adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study. (2024)